logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
A

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7
Papers471
Citations
Journal Papers 466
Publication Date
delete
Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-30
delete0
PREAI
deleteSaqr G. Alsakarneh; Brian D. Juran; Jenna Fernandez; Mrinal Patnaik; Gregory J. Gores; Nicholas F. LaRusso; Konstantinos N. Lazaridis
deleteShare
deleteSave
Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-29
delete0
deleteOAAI
deleteÁlvaro Díaz-González; Bastian Engel; Manuel Hernández-Guerra; Indhira Pérez-Medrano; Beatriz Mateos; Rosa M. Morillas; Elena Gómez; Judith Gómez; Diana Horta; Isabel Conde; María Del Barrio; Ignasi Olivas; Ismael El Hajra; Mar Riveiro-Barciela; Ana Barreira-Díaz; Carmen López; Carmen Álvarez-Navascúes; Manuel Rodríguez Perálvarez; Elmar Jaeckel; Richard Taubert; María-Carlota Londoño
deleteShare
deleteSave
Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-29
delete0
PREAI
deleteAndrew J. Park; Bai L. Pan; Xingfei Pan; James Park; Jiahong Dong; Calvin Q. Pan
deleteShare
deleteSave
Letter: Timing Matters—Interpreting Colonic Gas Reduction With Gel-Forming Fibres
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-29
delete0
deleteOAAI
deletePeng-Fei Wang
deleteShare
deleteSave
Letter: Temporal Alignment of Proton Pump Inhibitor Exposure and Gastric Neuroendocrine Neoplasm Risk in Autoimmune Gastritis. Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-28
delete0
deleteOAAI
deleteSara Massironi; Marco Vincenzo Lenti; Edith Lahner; Antonio Di Sabatino; Silvio Danese
deleteShare
deleteSave
Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-28
delete0
PREAI
deleteMarianne Hupé; Nicolas Mathieu; Aurélien Amiot; Philippe Seksik; Maeva Charkaoui; Cyrielle Gilletta-de-Saint-Joseph; Arnaud Bourreille; Mélanie Serrero; Yoram Bouhnik; Maria Nachury; Xavier Roblin; Stéphane Nancey; Vered Abitbol; Jean-Marc Gornet; Céline Montuclard; Xavier Hébuterne; Thierry Paupard; Cléa Rouillon; Mehdi Kaassis; Pierre Andrau; Morgane Amil; Magalie Baudrant; Laurent Peyrin-Biroulet; Stéphane Paul; Eric Vicaut; David Laharie
deleteShare
deleteSave
Editorial: Beyond the Matrix—Upadacitinib in Real-World Refractory Crohn's Disease
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-27
delete0
deleteOAAI
deleteIria Bastón-Rey; Iago Rodríguez-Lago; Manuel Barreiro-de Acosta
deleteShare
deleteSave
Meta-Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-26
delete0
deleteOAAI
deleteIgor Boechat Silveira; Leonardo Corrêa Süffert; Gustavo André Pedral Diniz Leite; Milena Ramos Tomé; Sarah Quick Lourenço de Lima; Gabriel André Pedral Diniz Leite; Bernardo de Faria Moraes; Pedro Robson Costa Passos; Guilherme Grossi Lopes Cançado
deleteShare
deleteSave
Editorial: MetALD-ALD Prediction Index—A Scalable Biomarker for Alcohol Phenotyping Beyond PEth. Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-26
delete0
deleteOAAI
deleteYuge Li; Qian Zhang; Haorui Liu; Zhenyu Huo; Shanshan Wu
deleteShare
deleteSave
Letter: What Does MAPI-Informed ALD Classification Capture?
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-26
delete0
deleteOAAI
deleteZichen Yu
deleteShare
deleteSave
Letter: Proton Pump Inhibitor Prescribing in Autoimmune Gastritis—From Real-World Exposure to Indication-Driven Reassessment
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-26
delete0
deleteOAAI
deleteFrancesco Calabrese; Vincenzo Savarino; Edoardo V. Savarino; Edoardo G. Giannini; Elisa Marabotto
deleteShare
deleteSave
Pathogen-Specific Bloodstream Infections Associated With Tumour Necrosis Factor-α Inhibitors, Vedolizumab and Ustekinumab in Inflammatory Bowel Disease: A Danish Nationwide Case-Control Study 2010–2024
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-24
delete0
deleteOAAI
deleteCæcilie Leding; Alessandra Meddis; Jon Gitz Holler; Johan Burisch; Thomas Benfield
deleteShare
deleteSave
Letter: Temporal Alignment of Proton Pump Inhibitor Exposure and Gastric Neuroendocrine Neoplasm Risk in Autoimmune Gastritis
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-23
delete0
deleteOAAI
deleteGeorge Azzi; Sumaya Al-Ukaidey
deleteShare
deleteSave
Editorial: Treatment Sequencing in Inflammatory Bowel Disease—Does the Line Matter More Than the Mechanism? Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-23
delete0
deleteOAAI
deleteCarmen Yagüe Caballero; Santiago García-López; Diego Casas-Deza; the ENEIDA registry investigators
deleteShare
deleteSave
Editorial: Anti-Integrin αvβ6 Autoantibodies for Distinguishing Ulcerative Colitis From Crohn's Disease: Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-23
delete0
deleteOAAI
deleteSamuel Truniger; Stephan Brand
deleteShare
deleteSave
Editorial: Mass Screening for Coeliac Disease—Growing Evidence but Is It Enough?
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-23
delete0
deleteOAAI
deleteMarisa Stahl; Edwin Liu; Carlo Catassi
deleteShare
deleteSave
Letter: Frail, Not Forgotten: Closing the Loop Between Geriatric Assessment and IBD Care. Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-22
delete0
deleteOAAI
deleteA. B. Fons; P. W. J. Maljaars
deleteShare
deleteSave
Letter: When Survival Improves Without Less Recurrence: What Drives the TDF Advantage After HCC Resection? Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-22
delete0
deleteOAAI
deleteJaehong Jeong; Hye Won Lee
deleteShare
deleteSave
Letter: Methodological and Contextual Considerations for Time to Positivity of a Rapid HBsAg Assay. Authors' Reply
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-22
delete0
deleteOAAI
deleteMaria Buti; Ariadna Rando-Segura; Asegedech Asmamaw; Judit Romero; Asgeir Johannessen
deleteShare
deleteSave
Development and Prospective Validation of a Machine Learning-Based Mobile Application (CROHN'S AID) for Differentiating Crohn's Disease From Intestinal Tuberculosis in Tuberculosis-Endemic Regions
deleteALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
delete2026-09-22
delete0
PREAI
deleteSrikant Mohta; Rintu Kutum; Akshat Dhoundiyal; Ritvik Pendyala; Harshal Dev; Bhaskar Kante; Sudheer Kumar Vuyyuru; Peeyush Kumar; Himanshu Narang; Mridul Mahajan; Shubi Virmani; Mukesh Kumar; Stuti Bahl; Nikhil Jayswal; Prasenjit Das; Raju Sharma; Govind Makharia; Santanu Chaudhury; Saurabh Kedia; Tavpritesh Sethi; Ravi Holani; Vineet Ahuja
deleteShare
deleteSave